scholarly article | Q13442814 |
P2093 | author name string | Jing Li | |
Wei Dai | |||
Zhipeng Li | |||
Chuan Peng | |||
Haoqiang He | |||
Jianye Liang | |||
Chuanmiao Xie | |||
Sihui Zeng | |||
P2860 | cites work | Tumor vasculogenic mimicry predicts poor prognosis in cancer patients: a meta-analysis. | Q53168767 |
Monitoring the Process of Endostar-Induced Tumor Vascular Normalization by Non-contrast Intravoxel Incoherent Motion Diffusion-Weighted MRI | Q59329297 | ||
Using IVIM-MRI and R2⁎ Mapping to Differentiate Early Stage Liver Fibrosis in a Rat Model of Radiation-Induced Liver Fibrosis | Q60920411 | ||
Vasculogenic mimicry is associated with high tumor grade, invasion and metastasis, and short survival in patients with hepatocellular carcinoma | Q80252905 | ||
Hypoxia induced EMT: A review on the mechanism of tumor progression and metastasis in OSCC | Q88505553 | ||
The efficacy and safety of irinotecan ± bevacizumab compared with oxaliplatin ± bevacizumab for metastatic colorectal cancer: A meta-analysis | Q90418477 | ||
Pathological features of vessel co-option versus sprouting angiogenesis | Q90959444 | ||
Detection of Hyperacute Reactions of Desacetylvinblastine Monohydrazide in a Xenograft Model Using Intravoxel Incoherent Motion DWI and R2* Mapping | Q91278327 | ||
Diffusion Kurtosis at 3.0T as an in vivo Imaging Marker for Breast Cancer Characterization: Correlation With Prognostic Factors | Q91806826 | ||
The long non-coding RNA H19: an active player with multiple facets to sustain the hallmarks of cancer | Q92138905 | ||
Vessel co-option and resistance to anti-angiogenic therapy | Q92179124 | ||
Monitoring tumour microenvironment changes during anti-angiogenesis therapy using functional MRI | Q92421327 | ||
MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders | Q22065376 | ||
ZEB1: at the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance | Q27015111 | ||
Meta-analysis of oxaliplatin-based versus fluorouracil-based neoadjuvant chemoradiotherapy and adjuvant chemotherapy for locally advanced rectal cancer | Q33798353 | ||
Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy | Q34354300 | ||
Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma | Q34570747 | ||
Targeted therapies of cancer: Angiogenesis inhibition seems not enough | Q37796392 | ||
Cadherins and epithelial-to-mesenchymal transition | Q38088483 | ||
Tumour vasculogenic mimicry is associated with poor prognosis of human cancer patients: a systemic review and meta-analysis | Q38132938 | ||
Zinc finger E-box binding homeobox 1 promotes vasculogenic mimicry in colorectal cancer through induction of epithelial-to-mesenchymal transition | Q39418945 | ||
Monitoring and Targeting Anti-VEGF Induced Hypoxia within the Viable Tumor by 19F-MRI and Multispectral Analysis | Q42264735 | ||
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial | Q42677492 | ||
Computer-aided evaluation of the correlation between MRI morphology and immunohistochemical biomarkers or molecular subtypes in breast cancer | Q47095927 | ||
Desacetylvinblastine Monohydrazide Disrupts Tumor Vessels by Promoting VE-cadherin Internalization. | Q47139353 | ||
Hypoxia inducible factor (HIF) in the tumor microenvironment: friend or foe? | Q47893488 | ||
E-cadherin: Its dysregulation in carcinogenesis and clinical implications. | Q49570064 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | oxaliplatin | Q422327 |
vasculogenesis | Q1424593 | ||
P304 | page(s) | 1376 | |
P577 | publication date | 2020-08-18 | |
P1433 | published in | Frontiers in Oncology | Q26839986 |
P1476 | title | Application of IVIM-DWI in Detecting the Tumor Vasculogenic Mimicry Under Antiangiogenesis Combined With Oxaliplatin Treatment | |
P478 | volume | 10 |
Search more.